Shantanu Gaur commented: Real-world use of GLP-1s has highlighted three critical issues: poor medication adherence and wrap-around support, muscle and bone mass loss, and untenable cost to the healthcare system.7 ADDRESSING MENTAL HEALTH IMPACT An emerging focus in the field is understanding and managing the psychological aspects of GLP-1 therapy
The clinical side runs through licensed providers who review your free assessment, personalize the program, and stay available through included support
Randomized trials monitoring GLP-1 agonists for cardiovascular and metabolic outcomes have not flagged increased cancer risk in interim safety analyses
A conservative estimate suggests that a 50-pound weight regain costs $5,000 to $15,000 in direct healthcare costs over the following five years through increased medications, more frequent provider visits, and management of weight-related complications
Cam Hanes, Mike McKnight, and Peptides After Cocodona this year, Cam Hanes was criticized publicly (albeit technically indirectly) by Sage Canaday for taking the peptide BPC-157, a banned substance under World Anti Doping Agency (WADA) rules
